Advertisement
Baxter International Inc. (BAX)
NYSE - Nasdaq Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 36.73 |
| Open | 36.60 |
| Bid | 35.81 x 1000 |
| Ask | 36.72 x 800 |
| Day's Range | 35.84 - 36.78 |
| 52 Week Range | 31.75 - 44.01 |
| Volume | |
| Avg. Volume | 3,909,831 |
| Market Cap | 18.606B |
| Beta (5Y Monthly) | 0.59 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.30 |
| Earnings Date | Nov 08, 2024 |
| Forward Dividend & Yield | 1.16 (3.22%) |
| Ex-Dividend Date | Aug 30, 2024 |
| 1y Target Est | 40.84 |
- Business Wire
Baxter to Present at UBS Global Healthcare Conference
DEERFIELD, Ill., October 23, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:15 p.m. Pacific Time.
ZacksGrowing Biosimilars Business Supports ABT Stock, Macro Issues Hurt
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.